Is Marsh McLennan (MRSH) a risky stock?
As of July 21, 2026, Clavix grades Marsh McLennan (MRSH) B for risk, a composite score of 74 out of 100 on an A+ to F scale, which puts MRSH in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind MRSH's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how MRSH scores on each, as of July 21, 2026.
What's moving MRSH's risk right now
Company-specific signals Clavix flags behind MRSH's current grade, drawn from recent news and filings as of July 21, 2026.
Marsh is set to report earnings next week, and analysts expect growth but caution the company likely won't top consensus forecasts. That points to a muted or negative stock reaction even if the headline numbers improve.
Wealthfront, Sanctuary Advisors, and Calamos Advisors each opened new positions in Marsh & McLennan during the first quarter, per SEC filings. The buys are routine institutional activity and don't signal a major shift in news signal.
Marsh is teaming up with American Beacon to offer turnkey model portfolios to financial advisors, broadening its reach into wealth management. The deal opens a new revenue stream in the fast-growing advisor services market.
What a B grade means
On the Clavix A+ to F scale, MRSH's composite of 74 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell MRSH or any security. Grades are risk indicators, not predictions of return. Data may be delayed.